Form 8-K - Current report:
SEC Accession No. 0000950170-23-005329
Filing Date
2023-03-01
Accepted
2023-03-01 07:05:30
Documents
14
Period of Report
2023-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amrn-20230301.htm   iXBRL 8-K 69098
2 EX-99.1 amrn-ex99_1.htm EX-99 562770
3 GRAPHIC img114078973_0.jpg GRAPHIC 26945
  Complete submission text file 0000950170-23-005329.txt   824532

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrn-20230301_lab.xml EX-101.LAB 18470
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrn-20230301.xsd EX-101.SCH 2480
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrn-20230301_pre.xml EX-101.PRE 11543
8 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20230301_htm.xml XML 5003
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 23689678
SIC: 2834 Pharmaceutical Preparations